Address

Achillion Pharmaceuticals Inc
300 George Street
New Haven, CT 06511
United States

Open map

Phone
KANDO id: 137591

Corporate information

Registration country

Official identities

US CIK 0001070336

Company type

Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease.

Funding rounds

Venture


( )


N/A


( )

Profile Country
Clarus Ventures LLC Life sciences venture capital firm
Investor Growth Capital Inc (IGC) The wholly owned venture capital arm of Investor AB
ProQuest Investments

Profile Country Notes
Advent International Corp Private equity firm Initial investment.
Atlas Venture Early-stage venture capital firm that creates and invests in biotechnology startup companies in the US. Initial investment.
Connecticut Innovations Inc (CI) Initial investment.
Domain Associates LLC Venture capital firm focused on life sciences companies. Initial investment.
General Electric Co Initial investment.
Gilead Sciences Inc A biopharmaceutical company that discovers, develops and commercializes therapeutics. Initial investment.
Gilead Sciences Inc A biopharmaceutical company that discovers, develops and commercializes therapeutics. Initial investment.
Jefferies Capital Partners Initial investment.
KBL Healthcare Ventures Initial investment.
Noble Financial Group Initial investment.
Oakwood Medical Investors Initial investment.
Pappas Ventures (Pappas Capital) Initial investment.
Quaker BioVentures Inc Initial investment.
SGC Partners II LLC Initial investment.
SV Life Sciences Advisers Inc Initial investment.
The Bear Stearns Companies Inc (Bear Stearns) Initial investment.
Vivo Ventures LLC Initial investment.
Webster Financial Corp One of the largest regional banks in the U.S. Initial investment.


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials